Head-To-Head Review: Turning Point Brands (TPB) versus ADOCIA (ADOCY)

Turning Point Brands (NYSE: TPB) and ADOCIA (OTCMKTS:ADOCY) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

Earnings & Valuation

How to Become a New Pot Stock Millionaire

This table compares Turning Point Brands and ADOCIA’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Turning Point Brands $285.78 million 1.39 $20.20 million $1.08 19.15
ADOCIA $24.89 million 5.25 -$8.73 million ($1.27) -14.88

Turning Point Brands has higher revenue and earnings than ADOCIA. ADOCIA is trading at a lower price-to-earnings ratio than Turning Point Brands, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

19.8% of Turning Point Brands shares are held by institutional investors. 6.9% of Turning Point Brands shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings for Turning Point Brands and ADOCIA, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Turning Point Brands 0 0 3 0 3.00
ADOCIA 0 0 0 0 N/A

Turning Point Brands presently has a consensus target price of $19.00, suggesting a potential downside of 8.12%. Given Turning Point Brands’ higher possible upside, research analysts plainly believe Turning Point Brands is more favorable than ADOCIA.


Turning Point Brands pays an annual dividend of $0.16 per share and has a dividend yield of 0.8%. ADOCIA does not pay a dividend. Turning Point Brands pays out 14.8% of its earnings in the form of a dividend.


This table compares Turning Point Brands and ADOCIA’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Turning Point Brands 7.07% 55.65% 8.75%

Risk & Volatility

Turning Point Brands has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, ADOCIA has a beta of -0.02, suggesting that its share price is 102% less volatile than the S&P 500.


Turning Point Brands beats ADOCIA on 13 of the 15 factors compared between the two stocks.

About Turning Point Brands

Turning Point Brands, Inc., together with its subsidiaries, provides other tobacco products primarily in the United States. It operates through three segments: Smokeless Products, Smoking Products, and NewGen Products. The Smokeless Products segment manufactures and markets moist snuff; and contracts for and markets loose leaf chewing tobacco products. The Smoking Products segment imports and markets cigarette papers, tubes, and related products, as well as finished cigars, make-your-own cigar tobaccos, and cigar wraps; and processes, packages, and markets pipe tobaccos. The NewGen Products segment markets and distributes liquid vapor products, tobacco vaporizer products, and other products without tobacco and nicotine, including e-cigarettes, e-liquids, vaporizers, and other related products; and distributes various assortments of vaping products to non-traditional retail outlets through VaporBeast and Vapor Shark, as well as distributes various vaping related products to individual consumers through Vapor Shark branded retail outlets. The company sells its products under the Zig-Zag, Beech-Nut, Stoker's, Trophy, Havana Blossom, Durango, Our Pride, Big Mountain, Appalachia, Springfield Standard, Snake River, Tequila Sunrise, Fred's Choice, Old Hillside, Red Cap, Tennessee Chew, VaporBeast, and Vapor Shark brands. It sells its products to wholesale distributors and retail merchants in the independent and chain convenience store, tobacco outlet, food store, mass merchandising, and drug store and non-traditional retail channels. The company was formerly known as North Atlantic Holding Company, Inc. and changed its name to Turning Point Brands, Inc. in November 2015. Turning Point Brands, Inc. was incorporated in 2004 and is headquartered in Louisville, Kentucky.


Adocia Société Anonyme, a clinical-stage biotechnology company, develops medicines for the treatment of diabetes from already-approved therapeutic molecules. Its proprietary BioChaperone technological platform is designed and developed from polymers, oligomers, and small organic compounds to enhance the effectiveness and/or safety of therapeutic proteins. The company’s clinical product pipeline includes four insulin formulations, including BioChaperone Lispro U100 and U200, which are ultra-rapid formulations of insulin analogs; HinsBet U100, rapid-acting formulation of human insulin; and BioChaperone Combo, a combination of basal insulin glargine and rapid-acting insulin lispro. It is also developing six preclinical products, such as BioChaperone Human Glucagon, an aqueous formulation of human glucagon; BioChaperone Glargine Dulaglutide and BioChaperone Glargine Liraglutide that are combinations of insulin glargine with GLP-1s; BioChaperone Lispro Pramlintide and BioChaperone Lispro Exenatide, which are combinations of insulin lispro with synergistic prandial hormones; and HinsBet U500, a concentrated, rapid-acting formulation of human insulin. The company was founded in 2005 and is headquartered in Lyon, France.

Receive News & Ratings for Turning Point Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Turning Point Brands and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply